M&A Deal Summary |
|
---|---|
Date | 2007-03-12 |
Target | Plus Orthopedics Holding AG |
Sector | Medical Products |
Buyer(s) | Smith & Nephew |
Sellers(s) | Invision |
Deal Type | Add-on Acquisition |
Deal Value | 889M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1856 |
Sector | Medical Products |
Employees | 18,452 |
Revenue | 5.5B USD (2023) |
Smith & Nephew is a British-based multinational medical equipment manufacturing company. Smith & Nephew was founded in 1856 and is based in Watford, United Kingdom.
DEAL STATS | # |
---|---|
Overall | 8 of 34 |
Sector (Medical Products) | 7 of 23 |
Type (Add-on Acquisition) | 7 of 25 |
Country (Switzerland) | 1 of 2 |
Year (2007) | 1 of 2 |
Size (of disclosed) | 2 of 15 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2006-07-11 |
OsteoBiologics
Wermelskirchen, Germany OsteoBiologics, Inc. located in San Antonio, Texas, develops and manufactures bioabsorbable polymeric scaffolds, films, and related instrumentation for the repair and replacement of bone and articular cartilage. In July 2006, the Company was sold to Smith & Nephew plc for $72.3 million. |
Buy | $72M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-05-01 |
BlueSky Medical Group
Carlsbad, California, United States BlueSky, which manufactures the Versatile 1 wound vacuum system, has an estimated 5% of the global market for pumps and accessories used in negative-pressure therapy. |
Buy | $110M |
Category | Private Equity Firm |
---|---|
Founded | 1996 |
PE ASSETS | 400M EUR |
Size | Middle-Market |
Type | Sector Agnostic |
Invision AG is a private equity firm focused on growth capital investments in European companies or companies with opportunities in Europe. Target sectors include information technology, software, electronics, telecommunications, medical devices, healthcare services, financial services, and media. Invision looks to invest between €20 and €100 million in businesses generating €25 and €200 million in sales. Invision was formed in 1996 as the corporate venture capital arm of Metro Holding. Invision is based in Zug, Switzerland.
DEAL STATS | # |
---|---|
Overall | 8 of 24 |
Sector (Medical Products) | 1 of 2 |
Type (Add-on Acquisition) | 2 of 8 |
Country (Switzerland) | 2 of 7 |
Year (2007) | 2 of 6 |
Size (of disclosed) | 1 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-01-01 |
Cosmo Pharmaceuticals
Lainate, Italy Cosmo is an emerging fully-integrated speciality pharmaceutical company that aims to become a global leader in the market of optimised therapies for selected gastro-intestinal diseases. The company's proprietary clinical development pipeline specifically addresses innovative treatments for Inflammatory Bowel Diseases (IBD), such as Ulcerative Colitis and Crohn's Disease, as well as for colon infections. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-03-27 |
Thommen Medical AG
Waldenburg, Switzerland Thommen Medical develops, manufactures and distributes a dental implant system under the brand name SPI, Swiss Precision Implant. |
Sell | - |